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chimney endografts for patients with juxtarenal aortic aneurysms
Konstantinos P. Donas, Markus Eisenack, Giuseppe Panuccio, Martin
Austermann, Nani Osada, Giovanni Torsello
Objective: To present endovascular techniques in the treatment of jux-
tarenal aortic aneurysms (JAAAs) in relation to surgical repair; this is the
“gold standard.”
Methods: Between January 2008 and December 2010, 90 consecutive
patients were diagnosed with primary degenerative JAAAs (5.0 cm) and
assigned prospectively to different operative strategies on the basis of
morphologic and clinical characteristics. In particular, 59 patients were
treated by endovascular means such as fenestrated endovascular abdom-
inal aortic repair (f-EVAR, n ¼ 29) or chimney endovascular abdominal
aortic repair (ch-EVAR, n ¼ 30) endografting, and 31 patients underwent
open repair (OR, n ¼ 31).
Results: Early procedure-related and all-cause (30-day) procedure-related
mortality was 0% for the endovascular group and 6.4% (n¼ 2/31) for the OR
group, due to systemic inﬂammatory response syndromewith consecutive
multi-organ failure (P ¼ .023). Persistent postoperative hemodialysis
occurred only after OR (2/31; 6.4%). The overall estimated pre- and post-
operative median estimated glomerular ﬁltration rate and creatinine
values were similar in the three subgroups. There was one left renal artery
occlusion for each endovascular subgroup presented with ﬂank pain and
treated by iliaco-renal bypass in both cases. Transfusion requirements and
length of hospital stay were signiﬁcantly less in the endovascular group
(P ¼ .014 and P ¼ .004, respectively).
Conclusions: Endovascular treatment of JAAA is a safe alternative for the
short-term management of JAAA.
Long-term results after accessory renal artery coverage during
endovascular aortic aneurysm repair
Joshua I. Greenberg, Chelsea Dorsey, Ronald L. Dalman, Jason T. Lee,
E.J. Harris, Tina Hernandez-Boussard, Matthew W. Mell
Objective: Current information regarding coverage of accessory renal
arteries (ARAs) during endovascular aneurysm repair (EVAR) is based on
small case series with limited follow-up. This study evaluates the
outcomes of ARA coverage in a large contemporary cohort.
Methods: Consecutive EVAR data from January 2004 to August 2010 were
collected in a prospective database at a University Hospital. Patient and
aneurysm-related characteristics, imaging studies, and ARA coverage
versus preservation were analyzed. Volumetric analysis of three-dimen-
sional reconstruction computed tomography scans was used to assess
renal infarction volume extent. Long-term renal function and overall
technical success of aneurysm exclusion were compared.q Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
doi:10.1016/S1078-5884(12)00485-6Results: A cohort of 426 EVARs was identiﬁed. ARAs were present in 69
patients with a mean follow-up of 27 months (range, 1 to 60 months).
Forty-ﬁve ARAs were covered in 40 patients; 29 patients had intentional
ARA preservation. Patient and anatomic characteristics were similar
between groups except that ARA coverage patients had shorter aneurysm
necks (P ¼ .03). Renal infarctions occurred in 84% of kidneys with covered
ARAs. There was no signiﬁcant deterioration in long-term glomerular
ﬁltration rate when compared with patients in the control group. No
difference in the rate of endoleak, secondary procedures, or the require-
ment for antihypertensive medications was found.
Conclusions: This study is the largest to date with the longest follow-up
relating to ARA coverage. Contrary to previous reports, renal infarction
after ARA coverage is common. Nevertheless, coverage is well tolerated
based upon preservation of renal function without additional morbidity.
These results support the long-term safety of ARA coverage for EVARwhen
necessary.
High prevalence of abdominal aortic aneurysms in brothers and
sisters of patients despite a low prevalence in the population
Anneli Linné, David Lindström, Rebecka Hultgren
Objective: Population-based screening for abdominal aortic aneurysms
(AAAs) in elderly men is organized in many regions and countries in the
Western world, and the prevalence of disease is reported to decline.
Whether the prevalence among thosewith a family history also is declining
is unknown. The primary purpose of this studywas to assess the prevalence
of AAAs among siblings of persons with AAAs and to investigate the
proportion of siblings already diagnosed by opportunistic screening.
Methods: Patients treated for AAAs from January 2008 through December
2010 (n ¼ 412) in Stockholm, Sweden, were screened for siblings. Seven
hundred seventy-nine siblings were identiﬁed. All siblings <80 years
residing in Stockholm County were considered eligible and were invited to
participate in the study (n ¼ 174). Deceased siblings were not included in
the study, regardless of the cause of death. One hundred ﬁfty siblings were
enrolled in the study after informed consent was provided. One hundred
thirty-four siblings were screened for AAAs with ultrasound scan and
maximum aortic, infrarenal, anteroposterior, external (outer-to-outer)
aortic diameter was measured. Characteristics of siblings with and without
AAAs were compared.
Results: The mean age of the screened siblings was 66.4 years (standard
deviation, 7.1). Of the siblings, 11% were found to have an AAA,17% (n¼ 11)
of the brothers, and 6% (n ¼ 5) of the sisters. Only 11% of the siblings were
screened for AAAs before the study. One of 16 siblings with AAAs was <65
years. Ever smoking was evident in 81% of the AAA siblings compared to
59% in the non-AAA siblings. Factors associatedwith increased risk of AAAs
in the multivariate regression analysis were: male sex (odds ratio, 3.4; 95%
conﬁdence interval, 1.1-10.8; P ¼ .04) and age >65 (odds ratio, 10.8; 95%
conﬁdence interval, 1.3-86.4; P ¼ .03). Ever smoking was not statistically
signiﬁcant as a risk.
Abstracts / European Journal of Vascular and Endovascular Surgery 44 (2012) 232e234 233Conclusions: A strikingly high prevalence of AAAs in siblings was found as
compared to the reported declining aneurysm prevalence in elderlymen in
the Western world. Systematic improvements regarding screening of ﬁrst-
degree relatives is mandated and selective screening of siblings is an
underused tool to prevent death from aneurysm disease, both among men
and women.
Analysis of Florida and New York state hospital discharges suggests
that carotid stenting in symptomatic women is associated with
signiﬁcant increase in mortality and perioperative morbidity
compared with carotid endarterectomy
Ageliki G. Vouyouka, Natalia N. Egorova, Eugene A. Sosunov, Alan J.
Moskowitz, Annetine Gelijns, Michael Marin, Peter L. Faries
Background: Although large randomized studies have established the
efﬁcacy and safety of carotid endarterectomy (CEA) and, recently, carotid
artery stenting (CAS), the under-representation of women in these trials
leaves the comparison of risks to beneﬁts of performing these procedures
on women an open question. To address this issue, we reviewed the
hospital outcomes and delineated patient characteristics predicting
outcome in women undergoing carotid interventions using New York and
Florida statewide hospital discharge databases.
Methods: We analyzed in-hospital mortality, postoperative stroke, cardiac
postoperative complications, and combined postoperative stoke and
mortality in 20,613 CEA or CAS hospitalizations for the years 2007 to 2009.
Univariate and multiple logistic regression analyses of variables were
performed.
Results: CEAwasperformed in16,576asymptomatic and1744 symptomatic
women and CAS in 1943 asymptomatic and 350 symptomatic women.
Compared with CAS, CEA rates, in asymptomatic vs symptomatic, were
signiﬁcantly lower for in-hospital mortality (0.3% vs 0.8% and 0.4% vs 3.4%),
stroke (1.5% vs 2.6% and 3.5% vs 9.4%), and combined stroke/mortality (1.7%
vs 3.1% and 3.8% vs 10.9%). In cohorts matched by propensity scores, the
same trend favoring CEA remained signiﬁcant in symptomatic women.
Therewas no difference in cardiac complication rates among asymptomatic
women, but among symptomatic woman cardiac complicationsweremore
frequent after CAS (10.6% vs 6.5%; P¼ .0077). Among symptomatic women,
the presence of renal disease, coronary artery disease, or age 80 years
increased the risk of CAS over CEA threefold for the composite end point of
stroke or death. For asymptomatic women only in those with coronary
artery disease ordiabetes, therewas a statistical difference in the composite
mortality/stroke rates favoring CEA (1.9% vs 3.3% and 1.7% vs 3.4%, respec-
tively). Afteradjusting for relevant clinical anddemographic risk factors and
hospital annual volume, for CAS vs CEA, the risk of the composite end point
of stroke or mortality was 1.7-fold higher in symptomatic and 3.4-fold
higher in asymptomatic patients. Medicaid insurance, symptomatic
patient, history of cancer, and presence of heart failure on admission were
among other strong predictors of composite stroke/mortality outcome.
Conclusions: Databases reﬂecting real world practice performance and
management of carotid disease inwomen suggest that CEA comparedwith
CAS has overall better perioperative outcomes inwomen. Importantly, CAS
is associated with signiﬁcantly higher morbidity in certain clinical settings
and this should be taken into account when choosing a revascularization
procedure.
The impact of gender on outcome after infrainguinal arterial
reconstructions for peripheral occlusive disease
Enzo Ballotta, Mario Gruppo, Renata Lorenzetti, Giacomo Piatto, Giuseppe
DaGiau, Antonio Toniato
Objective: The role of gender on the outcome of infrainguinal arterial
revascularization (IAR) for peripheral arterial occlusive disease remains
uncertain. This study analyzed the outcome of IARs performed over 15
years, stratifying the results by sex.
Methods: Details of consecutive patients undergoing primary IAR for
peripheral arterial occlusive disease from 1995 to 2009 at our institution
were prospectively stored in a vascular registry. Demographics, risk
factors, indications for surgery, inﬂow sources, outﬂow target vessels,types of conduit, and adverse outcomes were analyzed. Postoperative
surveillance included clinical examination supplemented with duplex
scans and ankle-brachial index measurements in all patients at discharge,
30 days, 6 months, and every 6 months thereafter. End points of the study,
ie, patency, limb salvage, and survival rates, were assessed using Kaplan-
Meier life-table analysis. The c2 or Fisher exact, Student t, and log-rank
tests were used to establish statistical signiﬁcance.
Results: Our sample consisted of 1459 IARs performed in 1333 patients,
comprising 496 women (37.2%; 531 IARs), who were a mean 3 years older
than the men (74 vs 71 years; P < .001) and had a higher incidence of
diabetes mellitus (52% vs 46%; P¼ .03) and surgery for limb salvage (91% vs
87%; P ¼ .02). An autogenous vein conduit (great or small saphenous, or
both, spliced, arm, or composite veins) was used in 87% of the IARs. No
deaths occurred perioperatively (30 days). The major and minor compli-
cation rates were comparable between men and women. At 10 years, the
primary patency rate was 47% in women vs 49% in men (P ¼ .67), the
assisted primary patency rate was, respectively, 53% vs 50% (P ¼ .69), the
secondary patency rate was 61% vs 61% (P¼ .66), limb salvage rate was 93%
vs 91% (P ¼ .54), and survival rate was 43% vs 49% (P ¼ .65). Stratifying by
type of conduit revealed no differences in patency or limb salvage rates.
Conclusions: Despite an older age and more advanced stages of disease on
presentation inwomen, IAR performed inwomen can achieve patency and
limb salvage rates statistically no different from those recorded in their
male counterparts, supporting the conviction that sex per se does not
inﬂuence the outcome of lower extremity revascularization.
Development and validation of a risk calculator for prediction of
mortality after infrainguinal bypass surgery
Prateek K. Gupta, Bala Ramanan, Thomas G. Lynch, Abhishek Sundaram,
Jason N. MacTaggart, Himani Gupta, Xiang Fang, Iraklis I. Pipinos
Objective: For peripheral arterial disease, infrainguinal bypass grafting
(BPG) carries a higher perioperative risk compared with peripheral
endovascular procedures. The choice between the open and endovas-
cular therapies is to an extent dependent on the expected periproce-
dural risk associated with each. Tools for estimating the periprocedural
risk in patients undergoing BPG have not been reported in the litera-
ture. The objective of this study was to develop and validate a calcu-
lator to estimate the risk of perioperative mortality 30 days of
elective BPG.
Methods: We identiﬁed 9556 patients (63.9% men) who underwent elec-
tive BPG from the 2007 to 2009 National Surgical Quality Improvement
Program data sets. Multivariable logistic regression analysis was per-
formed to identify risk factors associated with 30-day perioperative
mortality. Bootstrapping was used for internal validation. The risk factors
were subsequently used to develop a risk calculator.
Results: Patients had a median age of 68 years. The 30-day mortality rate
was 1.8% (n ¼ 170). Multivariable logistic regression analysis identiﬁed
seven preoperative predictors of 30-day mortality: increasing age,
systemic inﬂammatory response syndrome, chronic corticosteroid use,
chronic obstructive pulmonary disease, dependent functional status,
dialysis dependence, and lower extremity rest pain. Bootstrapping was
used for internal validation. The model demonstrated excellent discrimi-
nation (C statistic, 0.81; bias-corrected C statistic, 0.81) and calibration.
The validated risk model was used to develop an interactive risk calculator
using the logistic regression equation.
Conclusion: The validated risk calculator has excellent predictive ability for
30-daymortality in a patient after an elective BPG. It is anticipated to aid in
surgical decision making, informed patient consent, preoperative optimi-
zation, and consequently, risk reduction.
Use of a postoperative insulin protocol decreases wound infection in
diabetics undergoing lower extremity bypass
Fuyuki Hirashima, Reshma B. Patel, Julie E. Adams, Daniel J. Bertges,
Peter W. Callas, Georg Steinthorsson, Janet McSorley, Andrew C. Stanley
Objective: Strict glucose control in patients undergoing coronary bypass
grafting has been shown to decrease infectious complications,
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control reduced morbidity after lower extremity bypass (LEB).
Methods: A prospective pilot study at a single institution within the
Vascular Study Group of New England was conducted from January 2009
to December 2010. Patients with diabetes and without undergoing LEB
were placed on an intravenous (IV) insulin infusion for 3 days after surgery
with titration of blood glucose from 80 to 150 mg/dL. The IV insulin study
group (n ¼ 104) was compared to a historic control group (n ¼ 189) that
received standard insulin treatment from the preceding 3 years. The Fisher
exact test, t-tests, Wilcoxon rank-sum tests, c2, and logistic regression
analyses were used to compare in-hospital morbidity. Stratiﬁed analyses
were conducted to determine if ﬁndings differed based on the presence or
absence of diabetes.
Results: There was no difference in postoperative complications between
the two groups with regard to graft infection, myocardial infarction,
dysrhythmia, primary patency at discharge, or mortality. Patients in the
IV insulin group had signiﬁcantly fewer in-hospital wound infections (4%
vs 11%; odds ratio [OR], 0.32; 95% conﬁdence interval [CI], 0.11-0.96; P ¼
.047). This association strengthened after adjusting for potentially con-
founding baseline differences in gender, body mass index, and smoking
status (adjusted OR, 0.22; 95% CI, 0.05-0.84; P ¼ .03). When stratiﬁed by
presence of diabetes, wound infections were decreased in the IV insulin
group (0/44 [0%] vs 9/90 [10%]; P ¼ .03.). In patients without diabetes
treated with IV insulin, there was no signiﬁcant difference in wound
infections (7% vs 12%; P ¼ .42).
Conclusions: Strict glucose control with a postoperative insulin infu-
sion protocol signiﬁcantly decreased the incidence of postoperative
in-hospital wound infection in the diabetic population. These previ-
ously unreported ﬁndings from this single-institution prospective
study warrant further investigation.
Long-term results of femoral vein transposition for autogenous
arteriovenous hemodialysis access
Pierre Bourquelot, Marek Rawa, Olivier Van Laere, Gilbert Franco
Introduction: When all access options in the upper limbs have been
exhausted, an autogenous access in lower limb is a valuable alternative toarteriovenous grafts. We report our experience of transposition of the
femoral vein (tFV).
Methods: From June 1984 to June 2011, 70 patients underwent 72 tFV in two
centers (Paris and Meknès) with the same technique. All patients had
exhausted upper arm veins or had central vein obstructions. Patients were
followed by serial duplex scanning. All complications were recorded and
statistical analysis of patency was performed according to intention to treat
using the life-table method.
Results: The mean interval between initiation of dialysis and creation of
the tFV was 10 years. The sex ratio was even (one female/one male).
Mean age was 48 years (range, 1-84 years), and there were no post-
operative infections. Duplex measurements in 33 patients indicated high-
ﬂow: mean ¼ 1529  429 mL/min; range, 700-3000 mL/min. Two
immediate failures were observed and four patients were lost to follow-
up soon after the access creation. Ten patients (14%) experienced minor
complications (hematoma, ﬁve; lymphocele, one; delayed wound heal-
ing, two; distal edema, two) and 30 patients (42%) experienced mild
complications (femoral vein and outﬂow stenosis, 16; treated by percu-
taneous transluminal angioplasty, 13; or polytetraﬂuoroethylene patch,
three; puncture site complications, three [ischemia, two; infection, one];
reversible thrombosis, three [two surgical and one percutaneous
thrombectomy]; abandoned thrombosis, eight [11%] after a mean patency
of 8.1 years). Thirteen patients (18%) experienced major complications
necessitating ﬁstula ligation (ischemic complications in ﬁve diabetic
patients with peripheral arterial occlusive disease [one major amputation
included], lower leg compartment syndrome, one; acute venous hyper-
tension, two; secondary major edema, two; high-output cardiac failure,
one; bleeding, two). All the patent accesses (59/72) were utilized for
dialysis after a mean interval of 2  1 months (range, 1-7 months)
resulting in an 82% success rate. According to life-table analysis, the
primary patency rates at 1 and 9 years were 91%  4% and 45%  11%,
respectively. The secondary patency rates at 1 and 9 years were 84%  5%
and 56%  9%, respectively.
Conclusions: Femoral vein transposition in the lower limb is a valuable
alternative to arteriovenous grafts in terms of infection and long-term
patency. Secondary venous percutaneous angioplasties may be necessary.
High ﬂow rates are frequently observed and patient selection is essential to
avoid ischemic complications.
